Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

5 Jul 2013 17:45

TATE & LYLE PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) has been informed that Robert Gibber, a person discharging managerial responsibility, exercised options today under the Tate & Lyle 2003 Performance Share Plan to acquire 187,640 ordinary shares of 25 pence each at nil cost. All shares were sold at 855.07 pence per share on the London Stock Exchange. Mr Gibber has already met the requirements of the Company’s Executive Shareholding Policy.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

Lucie GilbertCompany Secretary

5 July 2013

Copyright Business Wire 2013

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.